β 2 ‐Adrenergic Receptor Gene Affects the Heart Rate Response of β‐Blockers: Evidence From 3 Clinical Studies-Reference-Cited by-同舟云学术

β 2 ‐Adrenergic Receptor Gene Affects the Heart Rate Response of β‐Blockers: Evidence From 3 Clinical Studies

Published:2019-05-14 Issue:11 Volume:59 Page:1462-1470
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Shahin Mohamed H.¹,Rouby Nihal El¹,Conrado Daniela J.²,Gonzalez Daniel³,Gong Yan¹,Lobmeyer Maximilian T.¹,Beitelshees Amber L.⁴,Boerwinkle Eric⁵,Gums John G.¹,Chapman Arlene⁶,Turner Stephen T.⁷,Pepine Carl J.⁸,Cooper‐DeHoff Rhonda M.¹⁸,Johnson Julie A.¹⁸

Affiliation:

1. Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, College of PharmacyUniversity of Florida Gainesville FL USA

2. Department of Pharmaceutics, College of PharmacyUniversity of Florida Gainesville FL USA

3. Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of PharmacyUniversity of North Carolina Chapel Hill NC USA

4. Department of MedicineUniversity of Maryland Baltimore MD USA

5. Human Genetics Center and Institute of Molecular MedicineUniversity of Texas Health Science Center Houston TX USA

6. Department of MedicineThe University of Chicago Chicago IL USA

7. Division of Nephrology and HypertensionDepartment of Internal Medicine, Mayo Clinic Rochester MN USA

8. Division of Cardiovascular Medicine, Department of MedicineUniversity of Florida, College of Medicine Gainesville FL USA

Funder

Foundation for the National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1443

Reference42 articles.

1. Adrenergic receptors and metabolism: role in development of cardiovascular disease

2. Adrenergic Nervous System in Heart Failure

3. Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure

4. The Role of β-Blockers as a Cornerstone of Cardiovascular Therapy

5. β-Blocker pharmacogenetics in heart failure

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine in cardiovascular therapeutics: Evaluating the role of pharmacogenetic analysis prior to drug treatment;Journal of Internal Medicine;2024-02-11

2. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome;Biomedicine & Pharmacotherapy;2023-12

3. Pharmacogenomic markers of metoprolol and α-OH-metoprolol concentrations: a genome-wide association study;Pharmacogenomics;2023-06

4. Adrenergic receptors gene polymorphisms and autonomic nervous control of heart and vascular tone;Physiological Research;2022-01-30

5. Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers;The Pharmacogenomics Journal;2021-10-12